Suite 705B, Level 7, St Vincent’s Clinic
438 Victoria Street, Darlinghurst NSW 2010
02 8382 6776
bryantreception@stvincents.com.au

Publications by David H. Bryant

DOWNLOAD HERE

  1. Milton, G.W., Williams, A.E.J. and Bryant, D.H. Radical dissection of the inguinal and iliac lymph nodes for malignant melanoma of the leg. British Journal of Surgery, 1968, 55:641-648.
  2. Bryant, D.H. The syndrome of inappropriate secretion of antidiuretic hormone in infectious pulmonary disease. Medical Journal of Australia, 1972, 1:1285-1288.
  3. Burns, M.W., Devitt, L., and Bryant, D.H. Why do sputum cultures fail to yield pathogens? Medical Journal of Australia, 1973, 20:768-769.
  4. Bryant, D.H., Burns, M.W. and Lazarus, L. New type of allergic asthma due to IgG “Reaginic” antribody. British Medical Journal, 1972, 4:589-592.
  5. Bryant, D.H., Burns, M.W. and Lazarus, L. The measurement of IgE in asthma by a new radioimmunoassay. Medical Journal of Australia, 1973, 2:71-73.
  6. Bryant, D.H., Weston. M., and Burns, M.W. The diagnosis of farmer’s lung. Medical Journal of Australia, 1973, 2:642-645.
  7. Bryant, D.H., Burns, M.W., Eakin, R. and Garrett, M. Allergic respiratory disease. Medical Journal of Australia, 1973, 1:516.
  8. Bryant, D.H., Burns, M.W. and Lazarus, L. Identification of IgG antibody as a carrier of reaginic activity in asthmatic patients. Journal of Allergy and Clinical Immunology, 1975, 56:417-428. -2-
  9. Bryant, D.H., Burns, M.W. and Lazarus, L. The correlation between skin tests, bronchial provocation tests and the serum level of IgE specific for common allergens in patients with asthma. Clinical and Experimental Allergy, 1975, 5:145-157.
  10. Bryant, D.H. and Burns, M.W. The relationship between bronchial histamine reactivity and atopic status. Clinical and Experimental Allergy, 1976, 6:373-381.
  11. Bryant, D.H. and Burns, M.W. Bronchial histamine reactivity: its relationship to the reactivity of the bronchi to allergens. Clinical and Experimental Allergy, 1976, 6:523-532.
  12. Bryant, D.H. and Pepys, J. Bronchial reactions to aerosol inhalant vehicle. British Medical Journal, 1976, 1(6021):1319-1320.
  13. Bryant, D.H. and Burns, M.W. Skin-prick test reactions to inhalant allergens is asthmatic patients. Medical Journal of Australia, 1976, 1:918-924.
  14. Burns, M.W., Devitt, L. and Bryant, D.H. Pneumonia in a city hospital. Medical Journal of Australia, 1976, 2:787-791.
  15. Bryant, D.H. and Kay, A.B. Cutaneous eosinophil accumulation in atopic and non-atopic individuals: the effect of an ECF-A tetrapeptide and histamine. Clinical Allergy, 1977, 7:211-217.
  16. Bryant, D.H., Turnbull, L.W. and Kay A.B. Eosinophil chemotaxis to an ECF-A tetrapeptide and histamine: the response in various disease states. Clinical Allergy, 1977, 7:219-226. -3-
  17. Bryant, D.H. and Kay, A.B. A possible diagnostic aid in patients with eosinophilia. Australian & New Zealand Journal of Medicine, 1977, 7:670.
  18. 1Taylor, A.P., Taylor, P., Bryant, D.H., Longbottom, J.L. and Pepys, J. False positive complement fixation tests with respiratory virus preparations in bird fanciers with allergic alveolitis. Thorax, 1977, 32:563-566.
  19. Bryant, D.H. Role of IgG in human asthma. p.315-327 in Asthma: Immunology, Pharmacology and Treatment, ed. by Lichtenstein, L. and Austen, K.F, 1977, Academic Press, New York.
  20. Bryant, D.H. Eosinophilia in association with bronchogenic carcinoma. Australian & New Zealand Journal of Medicine, 1978, 8:456.
  21. Bryant, D.H. Some pulmonary manifestations of allergy. Medical Journal of Australia, 1978, 2 (6 supplement):21-25.
  22. Bryant, D.H. Robinson, S. and Burns, M.W. Evaluation of a commercial RAST in the detection of allergen-specific IgE in patients with allergic respiratory disease. Australian & New Zealand Journal of Medicine, 1978, 8:455.
  23. Burns, M.W. and Bryant, D.H. Food allergy – a controversial subject. Medical Journal of Australia. 1978, 1:541-543.
  24. Bryant D.H. Variations in sputum histamine concentration in patients with disordered airways function. Australian & New Zealand Journal of Medicine, 1979, 9:483.
  25. Bryant, D.H. and Piu, A. Histamine content of sputum from patients with asthma and chronic bronchitis. Clinical & Experimental Allergy, 1982, 12:19-27. -4-
  26. Bittoun, R., Rimmer, J., and Bryant, D.H. Lung function testing in a smoking cessation clinic. Australian & New Zealand Journal of Medicine, 1982, 12:694.
  27. Rimmer, J., and Bryant, D.H. Clinical and laboratory evaluation of bronchial reactivity to inhaled antigen. Australian & New Zealand Journal of Medicine, 1982, 12:214-215.
  28. Bryant, D.H. Airways obstruction in patients with bronchiectasis. Australian & New Zealand Journal of Medicine, 1983, 13:544.
  29. Bryant, D.H. Allergies, mediators and asthma. Medical Journal of Australia, 1984, 141 (supplement 5):2-5.
  30. Bittoun, R. and Bryant, D.H. Hemaglobin concentration – the best indicator of smoking cessation in hospitalized patients. Australian & New Zealand Journal of Medicine, 1985, 15:490.
  31. Bryant, D.H. Occupational asthma. Medical Journal of Australia, 1985, 142:678-680.
  32. Bryant, D.H. Asthma due to insecticide sensitivity. Australian & New Zealand Journal of Medicine, 1985, 15:66-68.
  33. Rimmer, J., Currenti, F. and Bryant, D.H. Histamine releasability from bronchial mast cells. Australian & New Zealand Journal of Medicine, 1985, 15:493.
  34. Bryant, D.H. Nebulised ipratropium bromide in the treatment of acute asthma. Chest, 1985, 88:24-29. -5-
  35. Rimmer, J. and Bryant, D.H. Effect of hypo- and hyper-osmolarity on basophil histamine release. Clinical and Experimental Allergy, 1986, 16:221-230.
  36. Hill, D.J., Ekert, H. and Bryant, D.H. Episodic angioedema and hypereosinophilia in childhood. Journal of Allergy and Clinical Immunology, 1986, 78:122-123.
  37. Gibson, P.G., Bryant, D.H., Harkness, J., Munro, V.J., Penny, R. and Cooper, D.A. Pulmonary manifestations of the acquired immunodeficiency syndrome. Australian & New Zealand Journal of Medicine,1987, 17:551-556.
  38. Bryant, D.H., Rimmer, J., and Currenti, F. Increased histamine releasability from peripheral blood basophils after incubation with interferon. Australian & New Zealand Journal of Medicine, 1987, 17:S2
  39. Cairns, D.R, Szentirmay, A., Yeates, M., Fernandez, V., Gibson, P.G. and Bryant D.H. The pattern of interstitial lung disease in scleroderma and Sjogrens Syndrome. Australian & New Zealand Journal of Medicine, 1988, 18:554.
  40. Bryant, D.H. Anti-cholinergic drugs and their use in asthma. Progress in Clinical and Biological Research, 1988, 263:379-391.
  41. Rimmer, J., Gibson, P.G, and Bryant, D.H. Extension of pulmonary tuberculosis after fibreoptic bronchoscopy. Tubercle, 1988, 69:57-61.
  42. Gibson, P.G., Bryant, D.H., Morgan, G.W., Yeates, M., Fernandez, V., Penny, R. and Breit, S.N. Radiation-induced lung injury: A hypersensitivity pneumonitis? Annals of Internal Medicine, 1988, 109:288-291.
  43. Cooper, D.A., Marriott, D.J., Harkness, J.L. and Bryant, D.H. The acquired immunodeficiency syndrome and tuberculosis. Medical Journal of Australia, 1988, 149:714-715. -6-
  44. Gibson, P.G., Robinson, B.W.S., McLennan, G., Bryant, D.H. and Breit, S.N. The role of bronchoalveolar lavage in the assessment of diffuse lung diseases. Australian & New Zealand Journal of Medicine, 1989, 19:281-291.
  45. Breit, S.N., Cairns, D., Szentirmay, A., Callaghan, T., Gibson, P.G., Marks, G., Bryant, D.H. and Yeates, M. The presence of Sjogren’s Syndrome is a major determinant of the pattern of interstitial lung disease in scleroderma and other connective tissue diseases. Journal of Rheumatology, 1989, 16:1043-1049.
  46. Chapman, K.R., Bryant, D.H., Marlin, G.E., Mitchell, C., Ruffin, R., Persson, G., Kallen, A. and Ljungholm. A placebo-controlled dose-response study of enprophylline in the maintenance therapy of asthma. American Review of Respiratory Disease, 1989, 139:688-693
  47. Gibson, P.G., Breit, S.N. and Bryant, D.H, Hypoxia during bronchoalveolar lavage. Australian & New Zealand Journal of Medicine, 1990,20:39-43.
  48. Bryant, D.H. and Rogers, P. Oxitropium bromide: An acute dose response study of a new anticholinergic drug in combination with fenoterol in asthma and chronic bronchitis. Pulmonary Pharmacology, 1990, 3:55-58.
  49. Spratt, P., Glanville, A.R., MacDonald, P., Farnsworth, A., Bryant, D.H., Keogh, A. and Chang, V.P. Heart-lung transplantation in Australia: Early results of the St. Vincent’s program. Transplantation Proceedings, 1990, 22:2141-2142.
  50. Burke, W.M.J., Keogh, A., Maloney, P.J., Delprado, W., Bryant, D.H. and Spratt, P. Transmission of sarcoidosis via cardiac transplantation. Lancet, 1990, 336:1579. -7-
  51. Bittoun, R., McMahon, M. and Bryant, D.H. Smoking in hospitalized patients. Addictive Behaviors, 1991, vol. 16:79-81.
  52. Bryant, D.H. and Rogers, P. Allergic alveolitis due to wood-rot fungi. Allergy and Asthma Proceedings. 1991, 12:89-94.
  53. Bryant, D.H. Drug-induced pulmonary disease. Medical Journal of Australia, 1992, 156:802-805.
  54. Cairns, D., Shelley, L., Burke, W.M., Bryant, D.H., Yeates, M., Penny, R. and Breit, S.N. The differing patterns of interstitial lung involvement in connective tissue disease. Journal of Rheumatology, 1992, 19:1089-1095.
  55. Ramsay, S.C., Yeates, M., Burke, W., Bryant, D.H., Morgan, G.W. and Breit, S.N. Quantitative pulmonary gallium scanning in interstitial lung disease. European Journal of Nuclear Medicine, 1992, 19:80-85.
  56. Bryant, D.H. and Rogers, P. Effects of ipratropium bromide nebuliser solution with and without preservatives in the treatment of acute and stable asthma. Chest, 1992, 102:742-747.
  57. Burke, W.M.J., Roberts, C.M., Bryant, D.H., Cairns, D., Yeates, M., Morgan, G.W., Penny, R., Zaunders, J.J., and Breit, S.N. Smoking-induced changes in epithelial lining fluid volume, cell density and protein. European Respiratory Journal, 1992, 5:780-784.
  58. Roberts, C.M., Cairns, D., Bryant, D.H., Burke, W.M.J., Yeates, M., Penny, R., Zaunders, J.J. and Breit, S.N. Changes in epithelial lining fluid albumin associated with smoking and interstitial lung disease. European Respiratory Journal, 1993, 6:110-115. -8-
  59. Roberts, C.M., Foulcher, E., Zaunders, J.J., Bryant, D.H., Freund, J., Cairns, D. Penny, R., Morgan, G.W. and Breit, S.N. Radiation pneumonitis: A possible lymphocyte-mediated hypersensitivity reaction. Annals of Internal Medicine, 1993, 118:696-700.
  60. Bryant, D.H., Boscato, L.M., Mboloi, P., Stuart, M.C. Allergy to laboratory animals among animal handlers. Medical Journal of Australia, 1995, 163:415-418.
  61. Sandrini, A., Plit, M., Glanville, A., Bryant, D.H. and Yates, D.H. Effect of inhaled steroid withdrawal on exhaled nitric oxide in COPD. Thorax, 2003, 58:86.
  62. Bryant, C.E, & Bryant, D.H., Causes of death of in subjects with asbestosis. European Respiratory Journal, 2004, vol 24, supplement 48, 145.
  63. Bryant, C.E, & Bryant, D.H, Rate of decline of lung function in asbestosis. European Respiratory Journal, 2004, vol. 24, supplement 48, 479.
  64. Bryant, D.H. Pulmonary complications of bone marrow transplantation, p. 1454-1465, in Clinical Bone Marrow and Blood Stem Cell Transplantation, ed. by Atkinson, K. et al, 2004, Cambridge University Press, Cambridge, UK.
  65. Bryant, D.H. Obliterative bronchiolitis in haematopoetic stem cell transplantation: can it be treated? European Respiratory Journal, 2005, 25:402-404.
  66. Bryant, D.H. Rise in rates of mesothelioma, asbestosis and benign asbestos-related pleural disease in NSW over the last 15 years. European Respiratory Journal, 2006, vol. 28, supplement, 694. -9-
  67. Bryant, D.H, Prognosis in subjects with asbestosis. European Respiratory Journal, 2008, vol 32, supplement 52: 782.